Back to Search Start Over

Akero Therapeutics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

Source :
Plus Company Updates. August 30, 2024
Publication Year :
2024

Abstract

SOUTH SAN FRANCISCO: Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced that management [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Plus Company Updates
Publication Type :
News
Accession number :
edsgcl.807116158